Publications by authors named "Mayuko Furuta"

Claim this Profile
M
Mapping the genetic landscape establishing a tumor immune microenvironment favorable for anti-PD-1 response.
Daniel A Skelly, John P Graham, Mingshan Cheng, Mayuko Furuta, Andrew Walter

Cell Rep· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mapping the genetic landscape establishing a tumor immune microenvironment favorable for anti-PD-1 response in mice and humans.
Daniel A Skelly, John P Graham, Mingshan Cheng, Mayuko Furuta, Andrew Walter

bioRxiv· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Characterization of HBV integration patterns and timing in liver cancer and HBV-infected livers.
Mayuko Furuta, Hiroko Tanaka, Yuichi Shiraishi, Takuro Uchida, Michio Imamura

Oncotarget· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic characterization of biliary tract cancers identifies driver genes and predisposing mutations.
Christopher P Wardell, Masashi Fujita, Toru Yamada, Michele Simbolo, Matteo Fassan, Mayuko Furuta

J Hepatol· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of HBV integration patterns and timing in liver cancer and HBV-infected livers.
Mayuko Furuta, Hiroko Tanaka, Yuichi Shiraishi, Takuro Unida, Michio Imamura

Oncotarget· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Loss-of-function mutations in Zn-finger DNA-binding domain of cause aberrant transcriptional regulation in liver cancer.
Hiroaki Taniguchi, Akihiro Fujimoto, Hidetoshi Kono, Mayuko Furuta, Masashi Fujita

Oncotarget· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic landscape of colitis-associated cancer indicates the impact of chronic inflammation and its stratification by mutations in the Wnt signaling.
Masashi Fujita, Nagahide Matsubara, Ikuo Matsuda, Kazuhiro Maejima, Ayako Oosawa, Mayuko Furuta

Oncotarget· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Whole genome sequencing discriminates hepatocellular carcinoma with intrahepatic metastasis from multi-centric tumors.
Mayuko Furuta, Masaki Ueno, Akihiro Fujimoto, Shinya Hayami, Satoru Yasukawa

J Hepatol· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Whole-genome mutational landscape and characterization of noncoding and structural mutations in liver cancer.
Akihiro Fujimoto, Mayuko Furuta, Yasushi Totoki, Tatsuhiko Tsunoda, Mamoru Kato

Nat Genet· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erratum: Whole-genome mutational landscape and characterization of noncoding and structural mutations in liver cancer.
Akihiro Fujimoto, Mayuko Furuta, Yasushi Totoki, Tatsuhiko Tsunoda, Mamoru Kato

Nat Genet· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrated analysis of whole genome and transcriptome sequencing reveals diverse transcriptomic aberrations driven by somatic genomic changes in liver cancers.
Yuichi Shiraishi, Akihiro Fujimoto, Mayuko Furuta, Hiroko Tanaka, Ken-ichi Chiba

PLoS One· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating Tumor DNA Analysis for Liver Cancers and Its Usefulness as a Liquid Biopsy.
Atsushi Ono, Akihiro Fujimoto, Yujiro Yamamoto, Sakura Akamatsu, Nobuhiko Hiraga, Mayuko Furuta

Cell Mol Gastroenterol Hepatol· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Whole-genome mutational landscape of liver cancers displaying biliary phenotype reveals hepatitis impact and molecular diversity.
Akihiro Fujimoto, Mayuko Furuta, Yuichi Shiraishi, Kunihito Gotoh, Yoshiiku Kawakami

Nat Commun· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The tumor-suppressive miR-497-195 cluster targets multiple cell-cycle regulators in hepatocellular carcinoma.
Mayuko Furuta, Ken-ichi Kozaki, Kousuke Tanimoto, Shinji Tanaka, Shigeki Arii

PLoS One· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A practical method to detect SNVs and indels from whole genome and exome sequencing data.
Daichi Shigemizu, Akihiro Fujimoto, Shintaro Akiyama, Tetsuo Abe, Kaoru Nakano, Mayuko Furuta

Sci Rep· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potential of tumor-suppressive miR-596 targeting LGALS3BP as a therapeutic agent in oral cancer.
Hironori Endo, Tomoki Muramatsu, Mayuko Furuta, Narikazu Uzawa, Atiphan Pimkhaokham

Carcinogenesis· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrative array-based approach identifies MZB1 as a frequently methylated putative tumor suppressor in hepatocellular carcinoma.
Satoshi Matsumura, Issei Imoto, Ken-ichi Kozaki, Takeshi Matsui, Tomoki Muramatsu, Mayuko Furuta

Clin Cancer Res· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
miR-152 is a tumor suppressor microRNA that is silenced by DNA hypermethylation in endometrial cancer.
Tomohiko Tsuruta, Ken-Ichi Kozaki, Atsushi Uesugi, Mayuko Furuta, Akira Hirasawa

Cancer Res· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The tumor suppressive microRNA miR-218 targets the mTOR component Rictor and inhibits AKT phosphorylation in oral cancer.
Atsushi Uesugi, Ken-Ichi Kozaki, Tomohiko Tsuruta, Mayuko Furuta, Kei-Ichi Morita

Cancer Res· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
miR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepatocellular carcinoma.
Mayuko Furuta, Ken-ich Kozaki, Shinji Tanaka, Shigeki Arii, Issei Imoto

Carcinogenesis· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis